|
It was reported that the wire guide in a cook spectrum minocycline/rifampin impregnated double lumen central venous catheter kinked.When advancing the wire guide into the patient, the user encounter resistance.The wire guide was then removed and a kink was observed.A new device was obtained to successfully complete the procedure.As reported, the patient did not experience any adverse effects or require any additional procedures due to this occurrence.On 01jun2022, the device was returned to cook and elongation was noted, thus prompting this report.
|
|
Blank fields on this form indicate the information is unchanged, unknown, or unavailable.This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
|
Blank fields on this form indicate the information is unknown, unchanged or unavailable.Investigation ¿ evaluation: (b)(6) hospital (taiwan) informed cook on 16may2022 of an incident involving a cook spectrum minocycline/rifampin impregnated double lumen central venous catheter (rpn: c-udlm-801j-abrm-hc) from lot 13841292.The complainant reported that, during a central venous catheter insertion on (b)(6) 2022, resistance was felt when advancing the wire guide into patient.Upon withdrawal, the wire was deformed (kinked).Another device was used to complete the procedure.Further communication with the user facility clarified that the wire guide straightener was used.The patient did not experience any adverse effects due to this occurrence.Reviews of the documentation, including the complaint history, device history record, instructions for use (ifu) and quality control procedures, as well as a visual inspection of the returned device, were conducted during the investigation.One used hdoc-32-60-0-2.5-hts-mwg wire guide was returned for evaluation.The wire was found to be stretched/elongated upon a visual inspection.Additionally, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure prior to distribution.A review of the device history record (dhr) for lot 13841292 and supplied wire guide lot ic13750763 found no nonconformances that could have contributed to the reported failure mode.It should be noted that there was one other complaint associated with the final product lot number for the same failure mode.Cook also reviewed product labeling.The product ifu, c_t_udlm_rev2 ¿8 french double-lumen central venous catheter,¿ provides the following information to the user related to the reported failure mode: instructions for use: ¿4.Slide safe-t-j wire guide straightener (positioned on distal tip of wire guide) over ¿j¿ portion of wire guide.Pass straightened wire guide through needle; advance wire guide 5-10 cm into vessel.If straight wire is used, always advance soft, flexible end through needle hub and into vessel.If resistance is encountered during wire guide insertion, do not force wire guide.Withdrawal of wire guide through needle should be avoided; breakage may result.5.While maintaining wire guide position, withdraw needle and safe-t-j wire guide straightener.¿ evidence gathered upon review of dmr, dhr, ifu and evaluation of the returned device indicates the device was manufactured to specifications.There is no evidence of nonconforming material in house or in the field.Based on the information provided, examination of the returned product and the results of our investigation, it was concluded that a component failure contributed to the reported incident.The appropriate personnel have been notified.Per the risk assessment no further action is required.We will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|